Search results for "From ACP Internist"
System-wide changes improve diabetes care
A Success Story in the latest issue of ACP Internist describes a primary care intervention to improve HbA1c testing.
https://diabetes.acponline.org/archives/2016/09/16/7.htm
16 Sep 2016
No clear-cut choice among once-weekly GLP-1 receptor agonists
All once-weekly GLP-1 receptor agonists reduced HbA1c and fasting plasma glucose levels, and either no differences or clinically marginal differences were found among the drugs for blood pressure, blood lipid levels, and C-reactive protein levels, according to the systematic review and network meta-analysis.
https://diabetes.acponline.org/archives/2015/12/11/6.htm
11 Dec 2015
Aspirin primary prevention trial in Japan halted for lack of mortality benefit
Low-dose aspirin for primary prevention reduced nonfatal myocardial infarction, but not death from cardiovascular causes, in older Japanese patients, a recent study found.
https://diabetes.acponline.org/archives/2014/12/12/7.htm
12 Dec 2014
ADA conference coverage on kidneys, weight, and insulin switches
The American Diabetes Association (ADA) 2020 Scientific Sessions were held virtually in June and covered in the August ACP Hospitalist and September ACP Internist.
https://diabetes.acponline.org/archives/2020/09/11/8.htm
11 Sep 2020
Troponin concentration may help stratify risk in those with stable ischemic heart disease and diabetes
Researchers used a high-sensitivity assay to measure cardiac troponin T concentration at baseline, then analyzed whether it was associated with a composite end point (death from cardiovascular causes, myocardial infarction, or stroke).
https://diabetes.acponline.org/archives/2015/09/11/5.htm
11 Sep 2015
GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis
Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a recent analysis of previous trials found.
https://diabetes.acponline.org/archives/2014/10/10/6.htm
10 Oct 2014
Reconciling conflicting diabetes guidance
ACP Internist discusses disagreement among professional medical societies on appropriate glycemic control goals following ACP's recent guidance recommending a higher target HbA1c.
https://diabetes.acponline.org/archives/2018/06/08/8.htm
8 Jun 2018
Diabetes remission through diet may be doable, with support
An article in the May ACP Internist discusses how intensive lifestyle interventions may be able to send type 2 diabetes into remission for selected patients.
https://diabetes.acponline.org/archives/2018/05/11/8.htm
11 May 2018
Patients with diabetes facing vision loss at ever-earlier ages
The growing problem of diabetic retinopathy in young people and the need for response by primary care clinicians are discussed in the April ACP Internist.
https://diabetes.acponline.org/archives/2013/05/10/8.htm
10 May 2013
GLP-1 receptor agonists associated with thyroid cancer
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://diabetes.acponline.org/archives/2022/12/09/6.htm
9 Dec 2022